← Back

Wire · opportunities

Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer's disease

Published

22 August 2026

Topic

opportunities

Sectors

BiotechDiagnostics

Source

Read at the-innovation.org

Verified

Fusion42 · 22 August 2026 · Fusion42 review

Researchers have identified blood-based circular RNAs as a breakthrough tool for early diagnosis of Alzheimer's disease, offering a minimally invasive method to detect the condition earlier than current techniques.

This Wire brief sits within Fusion42's coverage of Biotech and Diagnostics.

◆ The Wire takeaway

You can now explore blood-based RNA tests to catch Alzheimer's earlier than before, creating a new diagnostic approach that could reshape market demand and clinical trials.

Coverage

1 source · 22 Aug 2026

Related on Wire

Topics

BiotechDiagnosticsalzheimerscircular-rnaearly-diagnosisbiotechdiagnostics